Status:
RECRUITING
Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients
Lead Sponsor:
Sindh Institute of Urology and Transplantation
Conditions:
Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if Ferric Carboxymaltose is a safe efficacious alternative to Iron Sucrose for treatment of Iron deficiency anemia in non-dialysis dependent chronic kidney ...
Detailed Description
Anemia is a common complication of chronic kidney disease with its prevalence increasing with disease progression. The major causes of anemia in patients who have CKD are iron and erythropoietin defic...
Eligibility Criteria
Inclusion
- Outpatients
- Between age 18-85 years
- Patients diagnosed with Chronic kidney disease having eGFR of less than 60 ml/kg/1.73m2 (not on maintenance dialysis)
Exclusion
- Patients on maintenance dialysis
- Patients with concomitant B12 or folate deficiency
- Patients receiving ESA therapy
- Patients with prior Iron replacement therapy within preceding 2 weeks
- Patients receiving blood transfusions within preceding 3 months
- Pregnant Females
- Patients with Upper GI Bleeding
- Patients with history of hematologic disorders, active malignancy or chronic inflammatory conditions like tuberculosis or ulcerative colitis
Key Trial Info
Start Date :
June 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT06994065
Start Date
June 2 2025
End Date
September 1 2025
Last Update
August 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sindh Institute of Urology and Transplantaion
Karachi, Sindh, Pakistan